Masimo Co. (NASDAQ:MASI)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $151.00 and traded as high as $158.34. Masimo shares last traded at $158.11, with a volume of 7,447 shares traded.
MASI has been the topic of several analyst reports. Piper Jaffray Companies reissued an “overweight” rating and set a $175.00 target price (up from $161.00) on shares of Masimo in a research report on Tuesday, December 17th. ValuEngine downgraded shares of Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, BidaskClub raised shares of Masimo from a “hold” rating to a “buy” rating in a research report on Monday, December 16th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $161.75.
The company has a market capitalization of $8.46 billion, a price-to-earnings ratio of 52.01, a P/E/G ratio of 1.95 and a beta of 1.13. The company has a 50-day moving average price of $156.01 and a 200-day moving average price of $151.08.
Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Wednesday, October 30th. The medical equipment provider reported $0.76 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.73 by $0.03. The company had revenue of $229.01 million for the quarter, compared to the consensus estimate of $221.92 million. Masimo had a return on equity of 17.32% and a net margin of 20.83%. The firm’s revenue was up 8.8% compared to the same quarter last year. During the same period last year, the business posted $0.71 earnings per share. On average, sell-side analysts forecast that Masimo Co. will post 3.17 earnings per share for the current fiscal year.
In other news, COO Bilal Muhsin sold 3,000 shares of the firm’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $155.00, for a total value of $465,000.00. Also, EVP Anand Sampath sold 15,000 shares of Masimo stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $155.00, for a total value of $2,325,000.00. Following the sale, the executive vice president now directly owns 27,518 shares in the company, valued at $4,265,290. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 56,000 shares of company stock worth $8,683,715. 11.50% of the stock is currently owned by company insiders.
A number of hedge funds have recently added to or reduced their stakes in MASI. Flagship Harbor Advisors LLC lifted its stake in Masimo by 45.7% during the third quarter. Flagship Harbor Advisors LLC now owns 236 shares of the medical equipment provider’s stock worth $35,000 after purchasing an additional 74 shares during the period. Private Capital Group LLC lifted its stake in Masimo by 92.1% during the second quarter. Private Capital Group LLC now owns 340 shares of the medical equipment provider’s stock worth $33,000 after purchasing an additional 163 shares during the period. Benjamin F. Edwards & Company Inc. lifted its stake in Masimo by 2,500.0% during the third quarter. Benjamin F. Edwards & Company Inc. now owns 520 shares of the medical equipment provider’s stock worth $77,000 after purchasing an additional 500 shares during the period. Carroll Financial Associates Inc. bought a new position in Masimo during the third quarter worth about $175,000. Finally, AMP Capital Investors Ltd bought a new position in Masimo during the second quarter worth about $204,000. 82.71% of the stock is currently owned by institutional investors and hedge funds.
Masimo Company Profile (NASDAQ:MASI)
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
See Also: What is the Consumer Price Index (CPI)?
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.